About us  |   Ahead of print   |   Current Issue   |   Archives  |   Search  |   Instructions   |    Subscribe   |    Submit Article   |    Advertise   |    Feedback   |    Top cited   |    e-Alerts
Journal of Cancer Research and Therapeutics
The official publication of Association of Radiation Oncologists of India (AROI)  
JCRT is now indexed with PubMed / MEDLINE.
 Login    Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 
  Search
 
  
 >  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 >  Article in PDF (1,638 KB)
 >  Citation Manager
 >  Access Statistics
 >  Reader Comments
 >  Email Alert *
 >  Add to My List *
* Registration required (free)  

 
 >  References
 >  Article Figures

 Article Access Statistics
    Viewed1104    
    Printed47    
    Emailed0    
    PDF Downloaded96    
    Comments [Add]    

Recommend this journal

 


 
   Table of Contents  
LETTER TO THE EDITOR - DOCUMENTING A CASE
Year : 2011  |  Volume : 7  |  Issue : 3  |  Page : 387-389
 

Second primary malignancy of breast in a patient of gastrointestinal stromal tumor presenting as fluoro-deoxyglucose-avid breast incidentaloma in fluoro-deoxyglucose-positron emission tomography


1 Department of Radiology, Tata Memorial Hospital, Parel, Mumbai, Maharashtra, India
2 Radiation Medicine Centre, Bhabha Atomic Research Centre, Mumbai, Maharashtra, India
3 Department of Surgery, Tata Memorial Hospital, Parel, Mumbai, Maharashtra, India
4 Department of Pathology, Tata Memorial Hospital, Parel, Mumbai, Maharashtra, India

Date of Web Publication2-Nov-2011

Correspondence Address:
Sandip Basu
Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe, Jerbai Wadia Road, Parel, Mumbai - 400 012, Maharashtra
India
Login to access the Email id


DOI: 10.4103/0973-1482.87031

PMID: 22044838

Get Permissions

 


How to cite this article:
Ramani SK, Basu S, Parmar V, Gujral S, Bibte S. Second primary malignancy of breast in a patient of gastrointestinal stromal tumor presenting as fluoro-deoxyglucose-avid breast incidentaloma in fluoro-deoxyglucose-positron emission tomography. J Can Res Ther 2011;7:387-9

How to cite this URL:
Ramani SK, Basu S, Parmar V, Gujral S, Bibte S. Second primary malignancy of breast in a patient of gastrointestinal stromal tumor presenting as fluoro-deoxyglucose-avid breast incidentaloma in fluoro-deoxyglucose-positron emission tomography. J Can Res Ther [serial online] 2011 [cited 2013 Jun 18];7:387-9. Available from: http://www.cancerjournal.net/text.asp?2011/7/3/387/87031


Sir,

A second primary in the breast in a patient of gastrointestinal stromal tumor (GIST) is described in this report. This was a serendipitous observation on the whole body flouro-deoxy glucose-positron emission tomography (FDG-PET) study. The patient, a 49-year-old female, an operated case of gastric GIST, underwent FDG-PET for a whole body disease survey and did not show any abnormal disease focus except for an intense (SUVmax 4.3) focus in the left breast [Figure 1]. The patient underwent mammography and guided biopsy to correlate this incidentally detected FDG-avid focus in the breast [Figure 2]. The final histopathology turned out to be infiltrating ductal carcinoma grade III [Figure 3], with triple negative breast carcinoma on immunohistochemistry. Several second primaries in the setting of GIST have been reported in the literature. The present association, to the best of our knowledge, is the first report of breast carcinoma in the setting of GIST.
Figure 1: study demonstrating an intense abnormal disease focus (SUVmax = 4.3) in the left breast

Click here to view
Figure 2: (a and b) Mammographic hook wire localization was done for the nonpalpable mass corresponding to the fl ouro-deoxy glucose-avid left breast focus and specimen radiography was performed showing the mass with the hook wire needle

Click here to view
Figure 3: Section shows infi ltrating ductal carcinoma (H and E, ×40). The hormone receptor status was triple negative (ER-/PR-/Her2-) on immunohistochemistry

Click here to view


Synchronous or metachronous second primaries in the setting of GIST have been reported in the literature including that of the non-GI system. [1],[2],[3],[4],[5] There is a solitary report of the association of carcinoma breast and GIST. [2] With the improved patient survival in GIST, reports of its association with other neoplasms are becoming more common. The present case upholds the value of incidental observation in whole body FDG-PET and the fact that disease may be detected when it is confined to the site of primary. Concurrent two different primary malignancies detected by whole body FDG-PET or PET/CT have been described to be of distinct advantage and the present observation of diagnosing this unsuspected second primary malignancy further substantiates this.

 
 > References Top

1.Basu S, Mohandas KM, Peshwe H, Asopa R, Vyawahare M. FDG-PET and PET/CT in the clinical management of gastrointestinal stromal tumor. Nucl Med Commun 2008;29:1026-39.  Back to cited text no. 1
[PUBMED]  [FULLTEXT]  
2.Schiavon G, Maki RG, Fornier M. GIST and breast cancer: 3 Case reports and a review of the literature. Curr Cancer Ther Rev 2009;5:100-4.  Back to cited text no. 2
    
3.Basu S, Nair N, Mohandas KM. FDG-avid thyroid incidentaloma in advanced gastrointestinal stromal tumor: Metachronous dual primaries. Indian J Gastroenterol 2007;26:146-7.  Back to cited text no. 3
[PUBMED]    
4.Lamba M, Verma S, Prokopetz R, Pierscianowski TA, Jabi M, Moyana T. Multiple cutaneous and uterine leiomyomas associated with gastric GIST. J Cutan Med Surg 2005;9:332-5.  Back to cited text no. 4
[PUBMED]  [FULLTEXT]  
5.Zachaus M, Plotner A, Weimann A, Ruf B. Multiple gastrointestinal stromal tumors in neurofibromatosis type 1. Med Klin (Munich) 2007;102:163-7.  Back to cited text no. 5
    


    Figures

  [Figure 1], [Figure 2], [Figure 3]



 

Top
Print this article  Email this article
  

    

Contact us | Sitemap | Advertise with us | What's New | Copyright and Disclaimer
© 2005 Journal of Cancer Research and Therapeutics
Published by Medknow
Online since 1st April '05